The microtubule-associated protein MAP2 is essential for development of early neuronal morphology and maintenance of adult neuronal morphology. Several splice variants exist, MAP2a4, with a lack of MAF' 2a in cat brain. MAP;! is widely used as a neuronal marker. In this study we compared five monoclonal antibodies (MAbs) against MAPZ. They show differences in the immunocytochemical distribution of MAP2 isoforms during development of the visual cortex and cerebellum of the cat. Local and temporal differences were seen with MAb AP18, an antibody directed against a phosphorylation-dependent epitope near the N-terminal end. In large pyramidal dendrites in visual cortex, the AP18 epitope remained in parts immunoreactive after treatment with alkaline phosphatase. Three MAbs, AP14, MT-01, and MT-02, recognized the central region of the M m b molecule, which is not present in MAP2c and 2d, and reacted with phosphotylation-independent epitopes. During the fmt postnatal week the immunostaining in cerebellum differed between antibodies in that some cellular elements in external and internal granular layers and Purkinje cells were stained to various
Introduction
Microtubules are essential components for cell differentiation and neuronal maturation (Seeds et al., 1970; Yamada et al., 1970) . Proteins associated with microtubules, named microtubule-associated proteins (MAPS), participate in this process (for review see Matus, 1991; Riederer, 1990; Tucker, 1990) . Of special interest in early dendritic development is MAP2 (Matus, 1993; Bernhardt and Matus, 1982) .
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Correspondence to: Dr. B. M. Riederer, Institut d'linatomie, Rue du Bugnon 9. 1005 Lausanne, Switzerland. degrees, whereas at later stages staining patterns were similar. At early stages, antibody MT-02 stained cell bodies and dendrites in cerebral cortex and cerebellum. With progressing maturation, immunoreactivity became restricted to distal parts of apical dendrites of pyramidal cells and was absent from perikarya and finer proximal dendrites in cortex. MT-02 did not stain MAP2 in cerebellum of adult animals. This study demonstrates that the immunocytochemical detection of MAP2 depends on modifications such as phosphorylation and conformational changes of the molecule, and that MAP2 staining patterns differ between MAbs. Phosphorylation and specific conformations in the molecule may be essential for modulating function and molecular stability of MAP2, and monoclonal antibodies against such sites may provide tools for studying the functional role of modifications. (J Histochem Cytochem 431269-1284 , 1995 KEY WORDS: Cat; Cerebellum; Cytoskeleton; Development; Immunohistochemistry; Microtubule-associated proteins; Monoclonal antibodies; Visual cortex.
Mokcul'ar Properties of MAP2
In rat brain MAP2 consists of two high molecular weight forms, MAP2a and MAPZb, both of approximately 280 KD Burgoyne and Cumming, 1984) , and several smaller embryonic forms of 65-70 KD, termed MAP2c (Garner and Matus, 1988; Riederer and Matus, 1985) . It was shown that these variants originate by alternative mRNA splicing from the same gene and that MAP2c lacks the middle sequence of MAP2b (Papandrikopoulou et al., 1989; Garner and Matus, 1988) . More recently, it was demonstrated that the low M, MAP2 is composed of two forms, a neuronal (MAP2c) and a glial one (MAPZd), the latter differing from MAP2c in that it contains an additional fourth repeat sequence in the microtubule binding domain near the C-terminal end . Full-length cDNA cloning, sequencing, and expression of rat MAP2b and 2c demonstrated that MAP2 is composed of 1830 amino acids and MAP2c of 467 amino acids, with several binding domains for CAMP-dependent protein kinase and calciumcalmodulin kinase (Kindler et al., 1990) .
Immunocytochemical Locahzation of MAP2 and velopment, stimulation of the visual cortex with light resulted in
Brain Development
By immunocytochemistry it was shown that in adult rat the two high molecular weight forms, MAP2a and 2b, are good neuronal markers and are abundant in neuronal perikarya and dendrites (Chamak et al., 1987; Bernhardt and Matus, 1984; Burgoyne and Cumming, 1984; Caceres et al., 1984; De Camilli et al., 1984; Matus et al., 1981; Izant and McIntosh, 1980) . MAP2c is absent in adults (Riederer and Matus, 1985) , but represents a juvenile form that is abundant during embryonic life, being found in axons and some glial cells (Tucker, 1990) . By using hippocampal primary cultures transfected with a MAP2c cDNA clone tagged with a myc tag, it was demonstrated that the neuronal form of MAP2c was located in axons and dendrites . Most MAP2c disappears around the time of synaptic maturation, whereas MAP2d sometimes persists into mature tissue Tucker et al., 1988; Riederer and Matus, 1985) .
During cat brain development, MAP2 b and MAP2c are both present at birth (Riederer and Innocenti, 1992) , and during subsequent weeks MAP2b increases transiently, reflecting increased dendritic growth (Vercelli et al., 1992; Weisskopf and Innocenti, 1991) . After this critical phase of development, MAP2c decreases and finally disappears towards adulthood (Riederer and Innocenti, 1992) . Similar developmental patterns are observed in other species (Garner and Matus, 1988; Riederer and Matus, 1985; Binder et al., 1984; Burgoyne and Cumming, 1984) . In contrast to other species, in cat almost no MAP2a is expressed.
Fzlnction una' Phosphorylation of MAP2
As to its function, MAP2 enhances microtubule polymerization and is involved in the formation of cross-bridges between microtubules and neurofilaments (Hirokawa et al., 1988) . Recently, it was postulated that MAP2 is a sensitive cross-linker and adjustable spacer in dendritic architecture because of its multitude of proteasesensitive sequences and a variety of phosphorylation sites within the molecule (Friedrich and Aszbdi, 1991) . Increased spacing between dendritic microtubules compared to those of axons could also be due to the longer projection domain of MAP2b in dendrites (Chen et al., 1992) . These functions must be crucial during dendritic maturation and could also play a role in dendritic branching (Matus. 1993; Friedrich and Aszbdi, 1991) . Several studies have suggested that phosphorylation regulates MAP2 function, because phosphorylated MAP2 is less effective in promoting microtubule polymerization (Murthy and Flavin, 1983; Yamamoto et al., 1983) , and phosphorylation of MAP2 to various degrees may affect MAP2 function in different ways (Brugg and Matus, 1991) . Phosphorylation of MAP could also play a role in changing its binding to other structural components (Sattilaro, 1986; Leterrier et al., 1982; Nishida et al.. 1981) , and it has been hypothesized that, like tau proteins, phosphorylated MAP2 may become a stiff molecule that may be essential in keeping some microtubules apart (Friedrich and AszBdi, 1991) . MAP2 contains over 86 predicted phosphorylation sites located along the MAP2 molecule, of which 80 are actually being phosphorylated (Friedrich and AszBdi, 1991) . However, the functional role of these modifications seem to be diverse and not related to only one type of function.
In the cat, during the critical period of ocular dominance de-dephosphorylation of MAP2 (Aoki and Siekevitz, 1985) . Moreover, MAP2 dephosphorylation appears to be linked to the activation of N-methyl-D-aspartate (NMDA) receptors and is involved in the morphological stability of dendrites (Halpain and Greengard, 1990) .
These results indicate that the modification of MAP2 is intimately related to specific neuronal activities and functions (Johnson and Jope, 1992) . Until now, AP18 is the only monoclonal antibody known to react with a phosphorylated site on the N-terminal end of rat MAP2a, b, c, and d with Ser136, and it was suggested to be phosphorylated by proline-dependent kinases such as MAP kinase, GSK-3, or cdk2 (Berling et al., 1994) . However, it is not certain that AP18 reacts with the same site in human MAP2 (Kalcheva et al., 1993) .
In close vicinity to Serl36 is a binding site for the regulatory subunit of the Type I1 AMP-dependent kinase (PKA) (Obar et al., 1989; Rubino et al., l989) , but the relationship to the AP18 epitope is not known. Given the molecular properties of MAP2, its well known immunocytochemical distribution, and the potential role of posttranslational modifications for the function of this protein, we have investigated a panel of monoclonal antibodies (MAbs) to address several questions. Is the immunocytochemical distribution between different antibodies always the same? Does MAP2 distribution change during postnatal development? And is the immunocytochemical detection dependent on phosphorylational and conformational changes of the MAP2 molecule?
Materials and Methods
Tissue Preparation. Adult cats (over 1 year) and kittens of different ages [day of birth = 0; postnatal ages (P) Days 1. 3, 11, 19, 28, 30, 39, 451 were obtained by timed pregnancies from a breeding colony. Animals were deeply anesthetized with sodium pentobarbital (50 mglkg) and perfused with phosphate buffered saline [ 5 mM phosphate (Merck; Darmstadt, Germany), pH 7.4, 0.9% sodium chloride (Merck) PBS] for biochemistry. The brain was frozen with dry ice and stored at -80°C. For biochemical experiments and for SDS-PAGE, tissue samples were prepared from the occipital lobe (visual areas 17 and 18) (Riederer and Innocenti, 1992) or cerebellum. For immunohistochemical analysis, adult cats and kittens of different ages were perfused for 20 min with 4% paraformaldehyde in PBS. Cerebral hemispheres and cerebellum were post-fixed for 6 hr and stored at 4°C in PBS with 0.05% Na-azide (Merck) for up to 2 months. Coronal sections from the occipital lobe (visual areas 17 and 18) and sagittal sections through the vermis of the cerebellum were prepared. Sections 50 pm thick were cut with an Oxford vibratome and processed for immunohistochemistry. Some vibratome sections were stored in a freeze-protecting solution [I50 g sucrose (Merck) and 200 mg Na-azide in 300 ml ethylglycol (Fluka; Buchs, Switzerland) and 500 ml PBS] and stored at -20°C for later analysis. MAP2 immunoreactivity in these sections was identical to that found in immediately processed sections.
Antibodies. Antibodies AP18 and AP14 were obtained from Dr. L. I. Binder (Tucker et al., 1988; Binder et al., 1984 Binder et al., ,1986 , and monoclone C was a gift from Dr. A. Matus (Huber and Matus, 1984) . Immunoglobulins of AP18 and AP14 are both of IgGl type. Monoclonal antibodies MT-01 and MT-02 were raised in Balbic mice. Bovine microtubules were used as immunogens and for initial screening. The immunization protocol, the techniques for fusion of spleen cells with mouse myeloma cells SpZlO. the screening. cloning, and subcloning methods, and ascites production are described elsewhere (Driber et al., 1988; Viklickq et al.. 1982) . Antibody MT-01 is of IgGl type; antibody MT-02 is an IgM. Electrophoresis and I"unob1ot.s. Proteins (50 pglslot) were separated on a 3.6-15% SDS-PAGE. Gels were either stained with Coomassie Blue (Fluka) or electrically transferred to nitrocellulose sheets BA-S 85 (Schleicher & Schuell; Dassel. Germany) and stained with MAbs to MAP2 (Riederer and Innocenti. 1992) . Normal horse serum (Swisscand; Zurich, Switzerland) at 10% in Tris-buffered saline (TBS) was used to block nonspecific reactivity. MAbs against MAP2 were used as hybridoma supernatants (diluted ]:IO), and ascites fluids (diluted 1:lOOO) for immunostaining nitrocellulose filters. Blots were incubated with secondary antibodies (rabbit anti-mouse Ig conjugated with peroxidase) (P260; Dako, Glostrup, Denmark) at a concentration of 1 pUml for 2-5 hr, and immunoreactivity was visualized with 4-chloro-1-naphthol (Fluka) as chromogen (Riederer and Innocenti, 1982) .
For peptide mapping, brain homogenates (1 mg brain proteins/ml PBS, without protease inhibitors) were kept for 1 hr at 37°C or incubated with 100 pg a-chymotrypsin from bovine pancreas (Calbiochem; San Diego, CA)/mg brain protein) for 5 min at 4°C. Samples were denatured with SDS sample buffer, separated on SDS-PAGE, and transferred to nitrocellulose. Immunoreactive peptides were identified on Western blots with the different MAbs.
Immunohistochemistry. Floating vibratome sections (50 pm thick) were exposed to anti-MAP2 antibodies overnight (hybridoma supernatants were used at 1:10 dilution, ascites fluid at 1:500 dilution), then to a secondary antibody with 1% peroxidase-conjugated rabbit anti-mouse IgG, and subsequently to 4-chloro-1-naphthol (Riederer and Innocenti, 1982) . Nonspecific binding was blocked by incubation with 3% fetal calf serum (Gibco Life Technologies; Paisley, UK) in TBS. Sections were mounted on glass slides, coverslipped. and analyzed by light microscopy.
Dephosphorylation of Vibratome Sections. Vibratome sections of 50pm thickness ("0.5 cmz area) from visual cortex and cerebellum of kittens at Day P3 and adult cats were exposed to alkaline phosphatase (molecular grade; Boehringer, Mannheim, Germany) for various lengths of time (20-48 hr) at 37°C. as previously described (Riederer, 1992) . The alkaline phosphatase was used at 50 Ulvibratome section in 300 p1 dephosphorylation buffer. In control vibratome sections, dephosphorylation was inhibited by 10 mM nitrophenyl phosphate (Boehringer), 50 mM sodium fluoride ( M a c k ) , or 500 pM sodium vanadate (BDH Chemicals, Poole, UK).
Dephosphorylation of Proteins. Fresh tissue samples of visual cortex and cerebellum of kittens at day P11 and adult cats were homogenized in the presence of a variety of protease inhibitors (10 pglml leupeptin, antipain. 5 pglml E64, 1 mM aminoethyl benzene sulfonylfluoride, AEMSF (all from Sigma, St Louis, MO)] and exposed to alkaline phosphatase for various lengths of time at 37'C as previously described (Riederer, 1992) . The use of phosphatase and kinase inhibitors is indicated in Results and figure legends. The alkaline phosphatase was used at 1 UllO pg homogenate proteins in dephosphorylation buffer. Dephosphorylation was inhibited by 10 mM nitrophenyl phosphate, 50 mM sodium fluoride, or 500 pM sodium vanadate. To prevent a rephosphorylation of MAP2 by endogenous kinases, 1000 U or -5 pglml of protein kinase inhibitor for PKA (P0300; Sigma) was used.
Results

Characterization by Western BlotJ
The different MAbs were characterized on Western blots for their reactivity with cat MAP2 isoforms in visual cortex and cerebellum of kittens at Days P3 and P28 after birth and adult animals (Figure 1) . All antibodies reacted with MAP2b in cortex ( Figure 1A ) and cerebellum ( Figure 1B ). This MAP2 form was most abundant in visual cortex at P28, and lesser amounts were present at P3 and in adult animals. MT-02 showed a reduced amount of MAP2b in adult tissue. In the cerebellum, most MAPZb was detected in adult tissue, with an increase in concentration during development as previously demonstrated (Riederer and Innocenti, 1992) . showed also an increase during cerebellar maturation. Monoclonals AP14 and MT-01 were identical in their reactivity. Noneof the applied antibodies detected MAP2a. Only two antibodies, MAb C and AP18, reacted in addition with MAP2c and 2d. The most MAP2c immunoreactivity was detected at P3 in cerebellum, and little or none was found at P28 and in adult. Most MAP2d was seen at P28. In cortex, the amounts of MAP2c and 2d were equally high at P3 and P28 and were absent in adult.
Phosphorylated MAP2
The immunoreactivity with MAbs C and AP18 was changed when visual cortex tissue of a juvenile kitten (P11) was treated with alkaline phosphatase for 24 hr at 37°C (Figures 2A and 2B , Lanes 2). After dephosphorylation, MAb C reacted with MAP2b undiminished and detected only a lower band in the Mr region of MAP2c.
It has been previously shown that dephosphorylated MAP2c has increased mobility on SDS-PAGE and therefore a slightly lower apparent molecular weight, and that MAb C is directed against a phosphorylation-independent epitope, and therefore is still reactive with dephosphorylated MAP2 (Riederer and Innocenti, 1992) . It should also be noted that after incubation for 24 hr at 37°C. owing to the presence of protease inhibitors the MAPZb molecule remained intact and no increase in breakdown products was observed. Of all the MAbs, only AP18 was directed against a phosphorylated site in MAPZ, because after dephosphorylation of juvenile brain tissue with alkaline phosphatase the AP18 immunoreactivity for MAP2b-d was reduced ( Figure 2B 
Epitope Mapping
To test the similarity between the different MAbs and to localize the epitopes on MAPZb, the visual cortex of an 11-day-old kitten and of an adult cat was enzymatically digested to be used for peptide mapping of MAP2 ( Figure 3 ). Brain tissue was homogenized in PBS in the absence of protease inhibitors and incubated for 1 hr at 37°C to allow reaction of the endogenous proteases. The peptide maps of juvenile and adult digested and stained with MAb AP18 and C ( Figures 3A and 3B , Lanes 1 and 2 ) showed that the proteolytic digests are very similar at both ages. However, PI 1 visual cortex after digestion with chymotrypsin (100 pg enzymdmg brain protein, incubated for 5 min at 4°C) showed proteolytic prod- Figure 2 Effects of MAP2 immunoreactivity with MAbs C and AP18 by dephosphorylation of visual cortex of kittens at postnatal day 11 Blots were stained with (A) MAb C and (6) MAb AP18 Samples were homogenized and incubated without (Lanes 1) or with alkaline phosphatase for 24 hr at 37% (Lanes 2-5) Note the decrease of APl8 immunoreactivity in dephosphorylated tissue (Lanes 2) Samples 3 and 5 contained additional alkaline phosphatase inhibitors (50 mM sodium fluoride and 500 )IM sodium vanadate) The samples in Lanes 4 and 5 received additional 1 11g/200 pl PKA inhibitor (Sigma) Note that in Lane 4 the AP18 epitope on MAP2b and low M, MAP2 was completely dephosphorylated because no rephosphorylation by endogenous kinase occurred Furthermore, addition of phosphatase inhibitors and PKA inhibitor had no effect on AP18 immunoreactivity and did not affect MAP2 degradation The locations of MAP2b. 2c. and 24 are indicated that APM is directed against a site near the C-terminal end of the middle sequence of MAPZb. onecould conclude that MT-02 must br directed against a site in the close vicinity. MT-01 and AP14 showed no reactivity on chymotryptic digests. Proteases V8 and trypsin did not provide immunoreactive fragments for all antibodies. despite protein loading of 100 pgllanc t o increase dctcctahility of fragments on blots.
Phosphorylated MA P2 in Visual Cortex
The visual cortex of an adult cat. when exposed to alkaline phosphatase and immunostained with MAb AP18. showed a considerable reduction in immunoreactivity ( Figure 4B ) in comparison to adjacent control sections stained with the same antibody ( Figure  4A ). After dephosphorylation some immunoreactivity persisted in the upper cortical layers. Even after extensive dephosphorylation for 48 hr the immunoreactivity was not complerely abolished and remained in the distal parts of dendrites in the border region bctween Layers I and 11 (not shown). At remaining immunoreactivity was seen in the distal parts of apical dendrites (Figure 4D) . Some perikarya and basal dendrites of ncurons in Layer 111 remained Stained, whereas complete disappcarance of these elements was seen in lower cortical layers. The presence of a PKA inhibitor did nor reduce such dendritic staining and gave the same staining pattern as treatment with alkaline phosphatase alone (not shown). For comparison, control tissue was incubated with alkaline phosphatase and with the phosphatase inhibitor nitrophcnyl phosphate (insert in Figure 4C ). lmmunostaining revealed a homogeneous somatodcndritic staining pattern throughout the cortical layers of the visual cortex. Two different staining patterns were seen with antibodies MT-01 and MT-02 in adult visual cortex ( Figure 5 ). Both antibodies are directed against MAP2b but do not react with MAP2c. Their immunological detection is independent of phosphorylation of MAP2, hccausc the same staining parterns were Seen in dcphosphorylatcd and non-treated tissue (not shown). MT-01 in Figure SA showed the same immunosraining as mosr antibodies directed against MAP2b. characterized by intense somatodcndritic staining of neuronal elements, seen as staining of apical and basal dcndrites and perikarya in Lavers I1 and 111. A different distribution of MAP2 immunoreactivity was seen with MT-02. This antibody immunostaincd the distal parts of the apical dendrites. Neither cell bodies nor basal dendrites were labeled. This is distinct from the staining pattern observed with AP18 in dephosphorylated correx tissue (Figure 4D) and where, in addition to that in the larger apical dendrites. some immunoreactivity remained in perikarya of upper cortical cell layers. This observation points to differences in the immunoreactivity of MAP2, which may depend on phosphory-lation of the epitope or which may be influenced by other effects modulating or masking MAP2 immunoreactivity.
Changes in M A P 2 Immunohistochemistry in Visual Cortex During Development
Differences in the immunocytochemical localization of MAP2 in the visual cortex of P3 and adult animals are shown in Figure 6 . AP18 stained both juvenile and adult tissue (Figures 6 A j and (,A:) . and. when the sections were dephosphorylated with alkaline phosphatase. immunodetecrion was reduced (Figures 6Bi and 6Bz) ar both ages. The staining patterns of antibodies AP18 (Figure 6A ). C (Figure K ) , (Figure 6D ). MT-02 ( Figure 6E ). and APl4 (Figure 6F) were not identical. and some elements that were either cell bodies. dendrites, or both were prominent. Furthermore. differences were observed in the neuropil staining. Antibody MT-02 was of particular interest. In the first postnatal weeks MT-02 also stained cell bodies. but at later ages only the dendriric parts remained immunostained and the immunoreactivity became restricted to apical dendrites.
Differences in immunocvtochemical staining between AP18 and C, or MT-01 and MT-02, were also demonstrated in the visual cortex of a P30 kitten ( Figure ; ). Variations among the differenr anribodies were demonstrated in subsequent sections in the same series of tissue. However, in several series of tissue we observed that some antibodies showed reduced immunoreactivity. whereas others were intense in staining. Tissues with poor immunosraining were not taken into account for the comparison among antibodies. Nevertheless. this observation is important and therefore is illustrated in Figure 7 . Antibody AP14 (Figure 7E) showed poor immunostaining ofvisual cortex of a P30 kitten compared with the other antibodies on subsequent sections (Figures GA-6D) . whereas an animal of similar age (P28) showed intense immunostaining with the same antibody ( Figure 7F ). This indicates that the preservarion of several MAP2 epitopes may depend on fixation conditions and that immunoreactivity may be lost by other unknown factors. such as partial proteolysis during tissue preparation.
Changes in M A P 2 Immunohistochemistry in Cerebellum During Develop men t
The represenration of phosphorylated MAP2 in cerebellum was rested with antibody AP18 (Figure 8 ). The epirope must be phosphorylated throughout postnatal development because dephosphorylation with alkaline phosphatase of P3 kitten cerebellum ( Figure  8B ) and cerebellum of an adult car ( Figure D) in both cases resulted in a considerable reduction in immunoreactivity.
A comparison of immunostaining of MAP2 with antibodies AP18. C. MT-01. and MT-02 revealed a remarkable difference in the distribution at early developmental stages ( Figures 9A1-9Dl ). ... . MT-02 stains only distal dendrites. On the same tissue APt4 gave a poor immunoreaction. whereas this antibody stained tissue of another animal at a similar age very well. Therefore, after treatments such as keeping of tissues at 4OC for several months. some epitopes may suffer earlier than others with different losses in immunoreactivity. Bar = 100 pm.
At P3, differences in intensity of immunostaining were seen in different lavers of the cerebellum. AP18 and Cstained differently in n o n s (parallel fibers) in the outer region of the molecular layer (owing to the presence of MAP2c). Furthermore, AP18 showed no stainingof Purkinje cells. suggesting that at that age MAP2 is not phos-phorylated at the epitope recognized by AP18, whereas the other MAbs clearly indicated the presence of MAP2 in Purkinje cells. Differences in staining intensity were also observed in granule cells of germinal and internal granular lavers. These differences were less evident at PI1 (Figure 6A2-6D2 ). Note the intense staining of EGL with antibodies AP18 and C. C shows less intense staining of granule cells. MT-02 is still intense in staining. comparable to MT-01. At P30 (Figures IOAI-IODI) , the staining between antibodies AP18. C and MT-01 was comparable, except that antibody C showed reduced immunoreactivity of granule cells, and MT-02 showed overall reduced immunoreactivity. The staining pattern of MAP2 in adult animals ( Figures IOA2-IOD2 ) was very similar with all antibodies except MT-02, with no immunoreactivity comparable to that of control sections.
Discussion
Our results are in accordance with previous studies DeCamilli et al.. 1984: Huber and Izant and McIntosh, 1980) showing that MAP2b is an essential protein during establishment of somatodendritic morphology. Several of the antibodies have been previously characterized (Tucker et al., 1988; Binder et al.. 1984 Binder et al.. ,1986 Huber and Matus, 1984) , in addition, two novel MAP2 antibodies were used to investigate differences in the immunocytochemical staining pattern. The novelty of our results include the following: (a) a further characterization of a panel of monoclonal antibodies for MAP2; (b) AP18 recognizes an epitope that is phosphorylated delayed in developing Purkinje cells; (c) several antibodies show different distribution within and between developing neurons; and (d) MT-02 does not react with MAP2 in cerebellum and detects MAP2 in adult cat cortex preferentially in distal dendrites of pyramidal cells.
Characterization of Antibodies Against MAP2
Digestion of brain tissue with endogenous proteases and immunodetection with MAbs AP18 and C showed the same proteolytic breakdown products of mainly MAP2b. Therefore, antibody C must react with the N-terminal site of MAP2b and 2c with an epitope close to epitope AP18, which was shown to be the phosphorylated Ser136 (Berling et al., 1994; Wille et al., 1992) . However, MAb C reacted with the epitope independent of phosphorylation. Antibodies AP14, MT-01, and MT-02 do not react with MAP2c and 2d. and therefore must be directed against the central 200 KD region present only in MAP2b. MT-01 detected in proteolytic digests produces similar products to those seen with AP18 and C. Therefore, the MT-01 epitope is located near the N-terminal part within the central 200 KD domain. Antibody MT-02 reacted with intact MAP2b and showed only a limited number of high Mr breakdown products, but recognized some additional fragments of around 100 KD. Given that these fragments are not identified with MT-01, the epitOpeS must be located closer to the C-terminal half of the central domain. Attempts should now be made to identify and locate the epitopes within [he MAP2 molecule and determine the mino acid sequences recognized by MAbs MT-ol and MT-02. Antibody AP14 has been reported to detect a site between amino acids 995 and 1333 (Kalcheva et al., 1993) . Note that none of the antibodies detected the Germinal end, a region that contains the three repeats of the microtubule-binding domain .
Phosphoryhtion of MAP2
Immunoreactive sites on the MAP2 molecule were identified for MAbs AP18 and AP14. MAb AP18 is directed against phos-phorylated Ser136 (Berling et al., 1994 : Wille et al., 1992 . an epitope present on all MAP2 isoforms. AP18 is the only antibody thus far known to recognize a phosphorylated epitope. This study also confirms that in cat brain AP18 is the only antibody to react with phosphorylated MAPZ. After alkaline phosphatase treatment. partial dephosphorylation was observed, in that larger apical dendrites remained immunoreactive. Several explanations are possible. The epitope is either less subject to dephosphorylation than smaller, basal dendrites, suggesting either a local difference in the susceptibility of MAP2 to alkaline phosphatase or a difference in local penetration of this enzyme, or there are differences in penetration of alkaline phosphatase and immunoglobulins. The possibility that MAP2 is partially degraded is unlikely, because MAP2 showed an intact MAP2 molecule on blots and immunohistochemistry was unaffected when tissue was exposed to alkaline phosphatase in the presence of phosphatase inhibitors. Remaining immunoreactivity could also be explained by the presence of protecting proteins which, by steric hindrance, do not permit access of alkaline phosphatase to the phosphorylated epitope but allow immunological detection.
In this study, the lack of rephosphorylation of the AP18 epitope in the presence of a PKA inhibitor suggests that CAMPdependent kinases may be involved in the phosphorylation of the epitope. However, studies by Berling et al. (1994) indicated that MAP2c, when phosphorylated by PKA, is not recognized by AP18, and protein kinases MAPK, cdk2 and GSK-3 are candidates to phosphorylate this epitope. Therefore, we cannot exclude the possibility that the PKA inhibitor used in this study may inhibit other types of kinases or may have indirect effects, and further investigations are advised.
The results with antibody MT-02 and its particular staining of apical dendrites are independent of phosphorylation, and the similarity of the staining to the remaining AP18 staining in larger distal dendrites after dephosphorylation could be a coincidence. However, both observations point to differences of MAP2 in distal parts of dendrites and suggest either that epitopes may be masked locally by other proteins or that MAP2 does not have the same conformation within a single neuron. It was shown that MAP2 immunoreactivity depends on p H and temperature during microwave treatment (Evers et al., 1994) . Retrieving antigenicity was proposed to occur due to hydrolysis and break of formaldehyde-induced crosslinks. However, optimal conditions differ for each antigen, and conformational changes in response to changes in antigen preservation cannot be excluded.
Deve~opment-dependent Changes in MAP2 Is0 forms
This study confirms that virtually no MAP2a can be found in cat brain (Riederer and Innocenti, 1992) and that none of the antibodies stained MAP2a in adult tissue. However, the molecular difference between MAP2a and MAP2b is currently unknown. One can exclude that MAP2a is generated by heavy phosphorylation of MAPZb, because no shift of MAP2a in its electrophoretic mobility is observed after dephosphorylation with alkaline phosphatase (unpublished observations). MAP2a may be generated by alternate splicing of pre-mRNA, as determined in cultured neuronal cells (Langkopf et al., 1994) , and high MI MAP2 may exist in several forms that contain four repeats in the microtubule-binding domain.
Previously, in developing cat cortex MAP2b increased during the early postnatal period reaching a maximal concentration at P19 (Riederer and Innocenti, 1992) , and its presence was related to changes occurring in the growth and remodeling of dendrites. It is evident that MAP2 is essential for neuronal morphology, and developmental patterns have been described extensively (Safei and Fischer, 1989; Tucker et al., 1988; Bernhardt et al., 1985; Riederer and Matus, 1985; Binder et al., 1984; Burgoyne and Cumming, 1984') . in comparison to these results there are discrepancies in the immunohistochemical distribution pattern with several antibodies, especially at an early developmental stage. All of the antibodies, with the exception of MT-02, were good immunocytochemical markers to identify neurons, because they decorated somata and dendrites, but at early development stages they revealed differences in immunostaining. This was most evident in the different layers of the cerebellum, with variable staining of Purkinje or granule cells in inner and outer layers. AP18 did not stain Purkinje cells before P11, whereas the other MAP2 antibodies indicated that MAP2 must be present at P6 in Purkinje cells of the same lobules. A differential maturation rate of Purkinje cell dendrites, as seen in rats (Goodlett et al., 1990) , is not the cause for such a delay. MAP2 in Purkinje cells is phosphorylated with a delay of several days after its expression. The absence of AP18 immunoreactivity in Purkinje cells during the first postnatal week suggests that phosphorylation of the APl8 epitope is not necessary during early dendritic outgrowth. The functional significance of retarded phosphorylation needs to be further investigated, but it may be related to the structural stability of microtubules or to cross-linking of MAP2, as discussed later. The other antibodies demonstrated at P6, although independent of phosphorylation, some variations in the expression of MAP2 by variations of immunostaining in only some cell types. In more mature tissue a more homogeneous staining among the different antibodies was seen. This strongly suggests that differences in MAP2 staining are due to local variations in the developmental state of neurons and that epitopes may either be blocked by interacting proteins in an on-and-off way or that MAP2 may be subject to conformational changes during early development. MT-02 is a good example of local and regional differences such as observed between pyramidal dendrites and cell bodies, and between cortex and cerebellum, respectively. The antibody MT-02 is of the IgM type, and therefore it is also possible that penetration of tissue is uneven due to differences in steric hindrance.
Antibodies AP18 and C, which react in addition with low Mr MAP2 forms, may also stain some axons and glial cells. MAP2c was most evident in cerebellum, in the earliest parallel fibers in upper MOL, and may be expressed in granule cells after their last cell division in EGL. This was already documented by Tucker et al. (1988) .
M A P2 Strzlctzlre
In view of these indications that immunohistochemical differences in MAP2 exist and that accurate identification may vary among antibodies, the question arises of whether MAP2 may change its conformation. MAP2 has little ordered structure (Vallee, 1990; Voter and Erickson, 1982) , and therefore steric hindrance of most of its sequences seems at first glance unlikely. Analysis of the full length MAP2b permits secondary structure predictions and suggests that the portion of MAP2b that extends from the microtubule surface is composed of an extensive number of a-helices separated by small turns, which may account for the extended yet flexible structure of MAP2 (Kindler et al., 1990) . Moreover, MAP2 forms a rod-like particle of 97-nm length, but it can also fold in a hairpin-like fashion, generating a 50-nm rod, as visualized by electron microscopy of glycerol-sprayed samples (Wille et al., 1992) . These observations indicate that MAP2 could be subject to conformational changes, and the immunoreactivity of some of our antibodies presented here may depend on the structural arrangement of the MAP2 molecule and could explain differences in the staining intensity and distribution between antibodies such as MT-01, MT-02, and AP14.
MAP2 function
It is known that phosphorylation of MAPS is an essential step during neuronal development for early plasticity or late stability (Riederer, 1992) . Several studies have shown that phosphorylation of MAP2a and b decreases their ability to induce tubulin polymerization and modifies their binding to microtubules, neurofilaments, and microfilaments (Hoshi et al., 1988; Sattilaro, 1986; Murthy and Flavin, 1983; Yamamoto et al., 1983; Leterrier et al., 1982; Nishida et al., 1981) . Because the tubulin binding site is at the C-terminal end, near the site for calcium/calmodulin-dependent kinase binding, one assumes that phosphorylation of Ser136 may not be involved in modulating binding of MAP2 to tubulin, nor in the formation of cross-bridges with the outermost part of the C-terminal end. Interestingly, MAP2 phosphorylated by CAMP-dependent but not by calcium/calmodulin-dependent kinase resulted in increased resistance to calpain-mediated proteolysis (Johnson and Foley, 1993) , and one could speculate that phosphorylation of Ser136 may inctease the stability of MAP2, a process that need not necessarily occur after de novo synthesis, as suggested by this study.
Functional aspects of MAP2 phosphorylation in vivo have been determined by Brugg and Matus (1991) , demonstrating that the extent of phosphorylation determines the binding of MAP2 to microtubules. Only 1% of the molecule contains the microtubule binding site, whereas the rest could also be phosphorylated. The large projection of MAP2 may help create steric hindrance of organelles along microtubules (Hagiwara et al., 1994; Heins et al., 1991) by interfering with kinesin-dependent microtubule motility. One could speculate that, by analogy with tau proteins in which phosphorylation stiffens the molecule (Hagestedt et al., 1989) , phosphorylation of MAP2 regulates the stiffness of the projection and may be involved in spacing of microtubules (Chen et al., 1992) and the branching process of dendrites (Matus, 1993 (Matus, ,1994 Friedrich and AszBdi, 1991) . The charge of phosphates may be enough to keep neighboring microtubules at a distance, allowing weak interactions for maintaining cytoplasmic fluidity and regulating competition for common microtubule binding sites, or could also indirectly influence the immunocytochemical detection.
Evidence that MAP2 is influenced by neuronal activity comes from experiments showing that dephosphorylation of MAP2 is linked to visual stimulation in cat visual cortex (Aoki and Siekevitz, 1985) , and dephosphorylation may be regulated by activation of a glutamate receptor, e.g., in hippocampus (Halpain and Greengard, 1990) . Pavlovian conditioning to tones changed the immunohistochemistry of MAP2 in the temporal cortex of rats (Woolf et al., 1994) , and many reports suggest that excitatory amino acids, potassium, or noxious treatments affect MAP2 and induce major changes in neuronal morphology (Diez-Guerra and Avila, 1993a,b; Diaz-Nido et al., 1993; Felipo et al., 1993; Kwei et al., 1993; Montoro et al., 1993; Tan et al., 1993) . All of these results imply chmges in the structural arrangement and conformation of MAP2 that per-haps may affect the immunohistochemical detection with some antibodies, and a careful characterization of the MAP2 antibodies seems advised. A variety of MAP2 antibodies may also prove to be useful tools for studying structural differences in MAP2 during development and aging, as well as those resulting from experimental manipulations.
